Clinical Trials

At Lehigh Valley Health Network, we are committed to providing our patients and community with the best possible care and treatments. Our research scientists are integrated with our clinical departments for a comprehensive, collaborative approach to research. Have a question about clinical trials? Contact the Network Office of Research and Innovation at 610-402-9543.

Showing 100 of 131 Clinical Trials

Clinical Research Trial

S1827 Lung Cancer

MRI Brain Surveillance Alone Versus MRI Surveillance and Prophylactic Cranial Irradiation (PCI): A Randomized Phase III Trial in Small-Cell Lung Cancer (MAVERICK)

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

S1827 Lung Cancer

MRI Brain Surveillance Alone Versus MRI Surveillance and Prophylactic Cranial Irradiation (PCI): A Randomized Phase III Trial in Small-Cell Lung Cancer (MAVERICK)

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

NRG-GI008

NRG-GI008 COLON ADJUVANT CHEMOTHERAPY BASED ON EVALUATION OF RESIDUAL DISEASE

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

NRG-GI008

NRG-GI008 COLON ADJUVANT CHEMOTHERAPY BASED ON EVALUATION OF RESIDUAL DISEASE

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

A022104 Rectal Cancer

Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

A022104 Rectal Cancer

Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

SWOG S1925 Lymphoma

Randomized, Phase III Study of Early Intervention with Venetoclax and Obinutuzumab Versus Delayed Therapy with Venetoclax and Obinutuzumab in Newly Diagnosed Asymptomatic High-Risk Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

SWOG S1925 Lymphoma

Randomized, Phase III Study of Early Intervention with Venetoclax and Obinutuzumab Versus Delayed Therapy with Venetoclax and Obinutuzumab in Newly Diagnosed Asymptomatic High-Risk Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

NRG-BN011

Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine®) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma

Doctor(s) Running This Study
Maged F. Khalil, MD